Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Indian drug maker Ranbaxy Laboratories has introduced Letrozole Tablets 2.5mg in the UK, Romania and France as a treatment for breast cancer.
Subscribe to our email newsletter
Ranbaxy‘s Letrozole Tablets 2.5mg are the generic version of Novartis’ Femara which is approved for the adjuvant treatment of postmenopausal women with hormone receptor-positive early stage breast cancer.
Ranbaxy (UK) Limited, Terapia Ranbaxy and Ranbaxy Pharmacie Generiques are expected to market the drug in the UK, Romania and France respectively.
Ranbaxy, Europe regional director Debashis Dasgupta said the product will be offered through pharmacies, retail and wholesale stores with immediate effect and will benefit the healthcare system in these EU markets.